Clinical Trials Directory

Trials / Unknown

UnknownNCT00132184

Vitamin D Treatment for Crohn´s Disease

Remission Keeping and Remission Inducing Effect by Vitamin-D in Crohns Disease, and in Vitro Vitamin-D Mediated T-Cell Immunomodulation

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
110 (planned)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine whether vitamin D treatment is effective in Crohn's disease.

Detailed description

Crohns Disease is an inflammatory disease of primarily the small intestine and colon. In recent years scientists have hypothesized that low blood vitamin-D levels play a role in the development of autoimmune diseases, including Crohns disease. The purpose of this study is to examine whether vitamin-D is effective in keeping remission in inactive Crohns Disease (double blind placebo controlled trial). The patients who have active disease in the placebo group (reach primary endpoint), will in an open setting receive a higher single dose vitamin-D and the effect will be measured within 4 weeks.

Conditions

Interventions

TypeNameDescription
DRUGVitamin D

Timeline

Start date
2005-09-01
Completion
2008-02-01
First posted
2005-08-19
Last updated
2007-04-13

Locations

4 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00132184. Inclusion in this directory is not an endorsement.

Vitamin D Treatment for Crohn´s Disease (NCT00132184) · Clinical Trials Directory